Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

SHA:688336 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	4,476	4,199	1,194	1,014	825.49	928.81
Revenue Growth	226.65%	251.81%	17.71%	22.84%	-11.12%	41.80%
Gross Profit Gross Profit Growth	4,140	3,867	888.86	790.99	620.68	718.79
Operating Income Operating Income Growth	3,326	3,121	206.58	191.21	-37.5	-108.79
Net Income Net Income Growth	3,088	2,899	704.58	294.61	49.3	18.06
Earnings Per Share EPS Growth	3.47	3.23	0.79	0.33	0.06	0.02
EPS Growth	264.63%	310.53%	137.52%	499.64%	166.67%	-

Revenue by Geography

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Mainland China Mainland China Growth	1,335
Other Countries and Regions Other Countries and Regions Growth	2,845
Total Total Growth	4,180

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	909.47	5,755	2,234	1,881	2,577	2,366
Total Debt Total Debt Growth	-	-	50.02	50.03	150.1	-
Net Cash (Debt) Net Cash Growth	909.47	5,755	2,184	1,831	2,427	2,366
Net Cash Growth	-47.24%	163.53%	19.24%	-24.55%	2.59%	-14.31%
Net Cash Per Share Net Cash Per Share Growth	1.02	6.41	2.44	2.06	2.72	2.71

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	203.95	3,043	281.14	416.35	233.49	-243.79
Capital Expenditures CapEx Growth	-276	-252.95	-280.78	-235.75	-221.26	-263.82
Free Cash Flow Free Cash Flow Growth	-72.05	2,791	0.35	180.61	12.23	-507.61
Free Cash Flow Growth	-	787511.40%	-99.80%	1376.67%	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	92.49%	92.08%	74.47%	78.00%	75.19%	77.39%
Operating Margin	74.31%	74.31%	17.31%	18.86%	-4.54%	-11.71%
Pretax Margin	78.80%	79.03%	59.29%	30.63%	3.51%	-5.75%
Profit Margin	68.99%	69.05%	59.03%	29.05%	5.97%	1.94%
FCF Margin	-1.61%	66.45%	0.03%	17.81%	1.48%	-54.65%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Dividend Per Share Dividend Per Share Growth	0.333	0.333	0.085	0.035
Dividend Per Share Growth	457.30%	292.81%	145.80%	-
Dividend Yield	1.03%	0.81%	0.57%	0.22%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	9.33	12.67	18.75	47.13	158.90	632.98
Forward PE	45.77	111.00	36.46	104.68	145.25	85.29
P/FCF Ratio	-	13.17	37289.16	76.87	640.46	-
PS Ratio	6.51	8.75	11.07	13.69	9.49	12.31

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error